GILD's strong HIV portfolio should maintain momentum for the company. The guidance for 2025 is impressive. We believe there ...

Gilead Sciences' Q4 earnings and sales beat estimates on higher HIV, oncology and liver disease drug sales. The stock is ...

AI in edtech can be bigger moment than the internet was 30 years ago as it takes an already great product and makes it even better, Moe said in the interview with Moneycontrol.

Despite a recent stock price drop, AMD remains a strong buy with growth potential in AI and data centers, positioning it as ...

A junior at Malvern Prep, Beck won the 50 yard freestyle and 100 butterfly at the recent Inter-Ac Swimming Invitational, and ...

RBC Capital Markets adjusted its outlook on Gilead Sciences (NASDAQ:GILD) stock, increasing the price target to $90 from the previous $84 while maintaining a Sector Perform rating. The adjustment ...

The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best ...

JMP Securities reaffirmed their confidence in Arch Capital's (NASDAQ:ACGL) potential in the property and casualty (P&C) insurance market, maintaining both the stock's price target at $125.00 and a ...

The paid packages — the Deluxe and Premium tiers — come at a higher cost relative to other tax-prep software we reviewed ... expensive tax products on the market, and the basic paid packages ...

Yerington Copper Project PFS on track for completion in June 2025 Yerington, Nevada--(Newsfile Corp. - February 4, 2025) - Lion Copper and Gold ...